Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Journal of Datta Meghe Institute of Medical Sciences University ; 17(5):S135-S140, 2022.
Article in English | Scopus | ID: covidwho-2040156

ABSTRACT

The whole world has been frightened because of the rapid rise in the number of cases and deaths due to novel coronavirus (officially referred to as coronavirus disease 2019 [COVID-19]) which was found in late 2019 in Wuhan city, China. Till date, the increased spread of novel coronavirus disease (COVID-19) is even now at an uncontrollable rate, and the amount of confirmed patients and mortality rate are still increasing at an exponential rate. Till October 1, 2020, from 216 different nations, regions, and territories, the World Health Organization received reports of 33,842,282 confirmed cases and 1,010,635 confirmed deaths. This virus causes a variety of symptoms which can range from mild illness to moderate illness. Difficulty in breathing and death occur in severe cases. The common earliest manifestations include fever, cough, fatigue, myalgia, diarrhea, and headaches. The disease is mainly transmitted through respiratory droplets from a person who is infected, via coughing, sneezing, or exhaling. Adding together expertize across various domains to search for new and effective solutions is the need of hour. Very little is known about how coronavirus affects the kidneys. There is no such proof that shows if people with renal diseases are more susceptible than the general public. Studies have been made over complications of coronavirus disease in patients with renal diseases and how to tackle them. This review article summarizes the analysis of the present situation with subject to coronavirus pandemic, its sequel on people with renal disorders, and the seriousness of the disease. Majorly, it gives an outline in management of this critical condition. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.

2.
Journal of Pharmaceutical Research International ; 33(38A):1-7, 2021.
Article in English | Web of Science | ID: covidwho-1362746

ABSTRACT

In 2019 December, a bunch of respiratory disorder cases associated with city's South China seller spot for sea food of unknown pathology was identified by the health authorities of Wuhan, China. And has been designated a public health emergency of international concern. Consequently, it was concluded that the virus spreads from individual-to-individual, and carriers are the most common source of Coronavirus growth. Novel Coronavirus, SARS-COV-2, was revealed by subsequent investigations and that was the initiative agent now at the core of a major outburst. To prevent or to reduce transmission, special focus and efforts were applied to vulnerable population including elderly people, children and health workers. And large scale measures were taken to lower communicable spread of COVID-19 from surveying a relation of (SARS) Severe Acute Respiratory Syndrome and (MERS) Middle East Respiratory Syndrome, where beta corona virus, which strike the lower respiratory tract and shows pneumonia in human being, was the causative agent. WHO announced outbreak of COVID-19 in the early First light of January 31, 2020 (Korea Standard Time) as "Public Health Emergency of International Concern" (PHEIC).An important collective goal was to reduce the outbreak and to flatten the peak of the outbreak curve. Delays result in significantly higher death tolls. In this review, we are trying to highlight the clinical features, investigations, WHO declaration of PHEIC, mode of transmission, effective Infection protocol to prevent this virulent infection from expansion and WHO 5 Movements because Hand Washing is a way of disinfecting a person's hands that considerably decreases likely pathogens (deadly germs) on the palms.

SELECTION OF CITATIONS
SEARCH DETAIL